2nd Next Gen Inhalation Delivery Summit
Evvnt Promotion / evvnt
04.06.2024 - 06.06.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 7:30 AM - 5:00 PM
Conference themes
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2262398-0?pid=4832
Speakers: Anna Cheng, Director - R and D Pulmonary Drug Delivery, Feldan Therapeutics , Colin Scott, CEO, Highland Airs Consultancy, Jaap Wieling, CEO, PureIMS, and more
URL:
Brochure: https://go.evvnt.com/2262398-0?pid=4832
Speakers: Anna Cheng, Director - R and D Pulmonary Drug Delivery, Feldan Therapeutics , Colin Scott, CEO, Highland Airs Consultancy, Jaap Wieling, CEO, PureIMS, and more
Enquiries and Registration:
Ms. Nandita Iyer
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."